A Randomized Phase III Trial Comparing FEC-Chemotherapy vs. EC-Doc-Chemotherapy in Patients with Primary Breast Cancer (ADEBAR)

The multicenter trial "A Randomized Phase III Trial Comparing FEC-Chemotherapy vs. EC-Doc-Chemotherapy in Patients with Primary Breast Cancer (ADEBAR)" enrolled 1363 patients with primary breast cancer. Our department analyses the quality of life results of this trial.

Funding: University Clinical Centre Ulm